FDA Inspection 1248566 — EUROAPI FRANCE

EUROAPI FRANCE — FEI 1463

The FDA completed an inspection of EUROAPI FRANCE on February 11, 2022 in Vertolaye. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 11, 2022
Fiscal Year
2022
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Vertolaye (France)

Additional Details

Mutual Recognition Agreement (MRA)